Arrowstreet Capital Portfolio holdings
AUM
$141B
1-Year Return
32.28%
This Quarter Return
+8.75%
1 Year Return
+32.28%
3 Year Return
+131.72%
5 Year Return
+249.71%
10 Year Return
+627.08%
AUM
$81.8B
AUM Growth
+$1.88B
(+2.3%)
Cap. Flow
-$3.52B
Cap. Flow
% of AUM
-4.31%
Top 10 Holdings %
Top 10 Hldgs %
21.06%
Holding
1,870
New
319
Increased
436
Reduced
629
Closed
457
Top Buys
| 1 |
AT&T
T
|
+$606M |
| 2 |
Apple
AAPL
|
+$569M |
| 3 |
Netflix
NFLX
|
+$370M |
| 4 |
Rio Tinto
RIO
|
+$328M |
| 5 |
Gilead Sciences
GILD
|
+$305M |
Top Sells
| 1 |
Procter & Gamble
PG
|
+$767M |
| 2 |
Micron Technology
MU
|
+$717M |
| 3 |
Salesforce
CRM
|
+$344M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$334M |
| 5 |
Nike
NKE
|
+$300M |
Sector Composition
| 1 | Technology | 31.99% |
| 2 | Healthcare | 15.24% |
| 3 | Financials | 12.27% |
| 4 | Consumer Discretionary | 10.58% |
| 5 | Communication Services | 7.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
251
Concentrix
CNXC
$3.4B
| $64.7M | 0.08% |
362,051
+108,529
| +43% | +$19.4M |
|
252
Pfizer
PFE
$141B
| $63.8M | 0.08% |
1,080,456
-23,744
| -2% | -$1.4M |
|
253
Bruker
BRKR
$4.87B
| $63.4M | 0.08% |
755,939
-1,203,097
| -61% | -$101M |
|
254
Bio-Rad Laboratories Class A
BIO
$7.74B
| $62.3M | 0.08% |
82,407
-7,704
| -9% | -$5.82M |
|
255
Sasol
SSL
$4.53B
| $62.2M | 0.08% |
3,789,762
+36,663
| +1% | +$601K |
|
256
iShares Core S&P 500 ETF
IVV
$675B
| $61.7M | 0.08% |
129,444
+16,634
| +15% | +$7.93M |
|
257
Canadian Pacific Kansas City
CP
$69.5B
| $61.4M | 0.08% |
853,563
+832,963
| +4,044% | +$59.9M |
|
258
ResMed
RMD
$40.2B
| $60.5M | 0.07% |
232,265
+41,998
| +22% | +$10.9M |
|
259
SPDR S&P 500 ETF Trust
SPY
$670B
| $60.3M | 0.07% |
126,939
-86,451
| -41% | -$41.1M |
|
260
ASE Group
ASX
$24.2B
| $59.9M | 0.07% |
7,665,425
+1,014,055
| +15% | +$7.92M |
|
261
iShare MSCI Eurozone ETF
EZU
$7.98B
| $59.3M | 0.07% |
1,209,717
+906,717
| +299% | +$44.4M |
|
262
SAP
SAP
$301B
| $58.8M | 0.07% |
419,942
+221,368
| +111% | +$31M |
|
263
Cooper Companies
COO
$13.6B
| $58.7M | 0.07% |
560,036
+191,636
| +52% | +$20.1M |
|
264
Brixmor Property Group
BRX
$8.6B
| $57.9M | 0.07% |
2,278,016
+19,944
| +0.9% | +$507K |
|
265
Estee Lauder
EL
$31.2B
| $57.8M | 0.07% |
156,167
-201,356
| -56% | -$74.5M |
|
266
First Bancorp
FBP
$3.54B
| $57M | 0.07% |
4,136,006
-310,113
| -7% | -$4.27M |
|
267
Gartner
IT
$18.3B
| $57M | 0.07% |
170,401
-9,104
| -5% | -$3.04M |
|
268
TransDigm Group
TDG
$72.9B
| $56.8M | 0.07% |
+89,246
| New | +$56.8M |
|
269
Abercrombie & Fitch
ANF
$4.44B
| $56.4M | 0.07% |
1,618,799
-451,602
| -22% | -$15.7M |
|
270
Incyte
INCY
$16.8B
| $56.1M | 0.07% |
764,580
+9,711
| +1% | +$713K |
|
271
Affiliated Managers Group
AMG
$6.7B
| $55M | 0.07% |
334,203
-131,230
| -28% | -$21.6M |
|
|
VRN
272
DELISTED
Veren
VRN
| $54.9M | 0.07% |
10,278,219
-1,083,903
| -10% | -$5.79M |
|
273
Radian Group
RDN
$4.81B
| $54.2M | 0.07% |
2,566,619
+903,912
| +54% | +$19.1M |
|
274
Diageo
DEO
$57.6B
| $54.2M | 0.07% |
246,276
+229,164
| +1,339% | +$50.4M |
|
275
EPR Properties
EPR
$4.31B
| $53.1M | 0.07% |
1,119,083
+44,813
| +4% | +$2.13M |
|